Construction work on Frederick Therapeutic Nucleic Acids Manufacturing Plant Expansion located in Colorado, the US commenced in Q1 2023, after the project was announced in Q1 2022. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q4 2026. To learn more about the Frederick Therapeutic Nucleic Acids Manufacturing Plant Expansion project, buy the profile here.
The project involves the expansion of a therapeutic nucleic acids manufacturing plant in Frederick, Colorado, the US.
Smarter leaders trust GlobalData
The project includes the following:
1. Construction of a production unit
2. Construction of a distribution unit
3. Construction of a packaging unit
4. Construction of a warehouse
5. Construction of an administrative space
6. Construction of a storage unit
7. Installation of machinery and equipment
8. Installation of safety and security systems
Construction on the project is expected to be completed by Q4 2026.
Switzerland-based CRB Group is the architect and engineering design consultant for the Frederick Therapeutic Nucleic Acids Manufacturing Plant Expansion, while Colorado State Government is the planning authority.
For more details on the Frederick Therapeutic Nucleic Acids Manufacturing Plant Expansion project, buy the profile here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
